tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market

Urogen Pharma (URGN) Cash flow

Compare
483 Followers

Urogen Pharma Cash Flow

URGN's free cash flow for Q4 2024 was $-13.73M. For the 2024 fiscal year, URGN's free cash flow was decreased by $-20.49M and operating cash flow was $-13.62M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -96.77M$ -76.38M$ -87.56M$ -84.89M$ -105.89M
Investing Cash Flow
$ -20.61M$ -953.00K$ 1.06M$ 4.07M$ 93.24M
Financing Cash Flow
$ 194.62M$ 116.93M$ 97.13M$ 72.32M$ 16.53M
End Cash Position
$ 173.06M$ 95.82M$ 56.22M$ 45.59M$ 54.09M
Free Cash Flow
$ -97.06M$ -76.57M$ -87.81M$ -85.64M$ -107.10M
Currency in USD

Urogen Pharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis